Risk assessment for hypocalcemia in therapeutic apheresis for kidney transplantation
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Chimezie Godswill Okwuonu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University of Virginia Health, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Hypocalcemia, Kidney Transplantation, Blood Component Removal. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: International Society of Nephrology.
Abstract (Originalsprache)
Introduction
The increase in the number of kidney transplants performed in the United States has been paralleled with an increase in the utilization of therapeutic apheresis (TA) for kidney transplant indications. Hypocalcemia remains a significant contributor to the adverse event in TA. The magnitude of hypocalcemia and its risk factors are scarcely discussed in literature.
Methods
This is a retrospective cohort review of adults from 18 years and above who received TA for kidney transplant‐related indications from January 1, 2017 to December 31, 2022. Data extracted included basic demographics, indication for apheresis, procedure characteristics, serum ionized calcium at the mid and end of procedure and serum creatinine at the beginning of apheresis, and so forth.
Results
Data from 131 patients and 860 sessions of TA were analyzed. Antibody‐mediated rejection (69%) and recurrent FSGS (15%) were the leading indications for TA. There were 60 (7%) TA sessions complicated by hypocalcemia. Of these, 53 (88%) occurred in the first session, 5 (8%) occurred in second session while 2 (4%) occurred in the third and subsequent sessions. Female sex, elevated serum creatinine and use of fresh frozen plasma‐ are the risk factors for hypocalcemia with odd's ratio of 2.34, 7.42, and 5.01, respectively. Binary logistic regression showed that elevated serum creatinine at the commencement of therapy is an independent predictor of hypocalcemia (adjusted odd's ratio = 3.31, p = 0.001).
Conclusion
Hypocalcemia is prevalent in this study. Clinical vigilance and tailored procedure will avert adverse consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, University of Virginia Health, Charlottesville, Virginia, USA.
- Federal Medical Centre Umuahia, Abia, Nigeria.
ORCID-Profile: Chimezie Godswill Okwuonu, Monarch Shah, Iram Rafique, Abdallah Saleh Abdelrazeq, Rasheed A Balogun
Förderung
- International Society of Nephrology
Zitieren
APA
Okwuonu, C. G., Shah, M., Rafique, I., Abdelrazeq, A. S., Dumor, K., & Balogun, R. A. (2024). Risk assessment for hypocalcemia in therapeutic apheresis for kidney transplantation. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14168
Vancouver
Okwuonu CG, Shah M, Rafique I, Abdelrazeq AS, Dumor K, Balogun RA. Risk assessment for hypocalcemia in therapeutic apheresis for kidney transplantation. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14168
BibTeX
@article{Okwuonu2024,
author = {Okwuonu, Chimezie Godswill and Shah, Monarch and Rafique, Iram and Abdelrazeq, Abdallah Saleh and Dumor, Korshie and Balogun, Rasheed A},
title = {Risk assessment for hypocalcemia in therapeutic apheresis for kidney transplantation},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14168}
}
EUVIMED